All In MedTech

Device Trial Radar · NCT06311331

Prospective Evaluation of Clinical and Radiographic Outcomes Following Total Talus Replacement (PROCLAIM)

Prospective Evaluation of Clinical and Radiographic Outcomes Following Total Talus Replacement (PROCLAIM): A Multicenter, Single Arm, Prospective, Post-approval Study for Patients Who Received the restor3d TTR Device to Evaluate Safety and Probable Benefit

Last checked: Nov 19, 2026Latest source record: Jan 8, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Enrolling by invitation

Status

Enrolling by invitation

Enrollment

50

Planned (sponsor's estimate)

Start

Nov 6, 2024

Primary completion

Nov 2031

Study completion Nov 2031

Sponsor

Lead sponsor
Restor3DNot on our public-company list
Sponsor type
Industry
Collaborators
OrthoCarolina Research Institute, Inc.
First posted
Mar 15, 2024

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 22 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a Humanitarian Device Exemption (HDE) approved device. The purpose of this study is to evaluate the continued safety and probable benefit of the restor3d Total Talus Replacement device in commercial use.

Conditions

  • Avascular Necrosis of the Talus
  • Talar Osteochondral Defect of Ankle
  • Talar Dysfunction

Interventions

  • Total Talus Replacement (TTR)Device

    The restor3d patient-specific TTR Implant and Instrumentation System is designed to replace a native talus bone that has been affected by a disease state or injury. The implant is an additively manufactured Cobalt Chromium alloy (ASTM F3213) construct produced by laser powder bed fusion. The data-driven design of the implant enables the patient to salvage their joint while maintaining ankle range of motion, reducing pain and improving physical function.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Proportion of participants who pass a composite of safety and probable benefit outcomesTime frame: At 5 years compared to baseline

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • OrthoCarolina Research Institute, Inc.

    Charlotte, North Carolina

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.